Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country

Table 3 Use of antiplatelet therapy in the Surviving Cohort

Follow-up	Usage of anti-platelets in survivor cohort (N = 22)		Significance (p-value)
Follow-up	No (N = 15); n (%)	Yes (N = 7); n (%)	Significance (p-value)
Episode of ACS			0.091
Yes	0	2 (28.6)
No	15 (100)	5 (71.4)
Episode of AVB			1.000
Yes	1 (6.7)	0
No	14 (93.3)	7 (100)

All numerical values as Mean ± S.D. Chi-squared test was used for categorical variables
*P-values are significant (< 0.05)

ISSN: 1471-230X